Infiniti, Mercedes-Benz, Lexus and Acura are among automakers that have started fielding vehicles that allow drivers to take their hands off the wheel. The cars stay on the road using a combination of radar and camera systems that track lane lines on the pavement. Most have alarms that remind drivers to put their hands back on after a few seconds. But not all: Infiniti's Q50 sedan can steer itself for miles without a finger on the wheel.
These come in addition to already available adaptive cruise control that adjusts to traffic speed, and collision prevention and mitigation systems that can slow or stop the vehicles. Some now can look beyond the car immediately ahead.
Top 5 Biotech Companies To Invest In 2015: MannKind Corporation(MNKD)
MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes and cancer in the United States, Europe, and Asia. Its lead product candidate, AFREZZA Inhalation Powder, an ultra rapid-acting insulin that is in Phase III clinical trials for the treatment of diabetes for the control of hyperglycemia. The company also develops MKC1106-MT, an investigational cancer immunotherapy product, which is in Phase II clinical trials for the treatment of adults with type 1 or type 2 diabetes; and MKC204, which is in preclinical development stage for the treatment of malignancies and inflammatory diseases. In addition, its products include MKC253 (GLP-1), a Phase I clinical trials product for the treatment of type 2 diabetes; MKC1106-PP, a Phase I clinical trials product for diverse tumor types, metastatic disease, and/or progressive and refractory disease; and MKC180, an obesity compound and MKC1106-NS , a cancer immunotherapy product that are in preclinical trials. MannKind Corporation was founded in 1991 and is headquartered in Valencia, California.
Advisors' Opinion:- [By Nate Pile]
MannKind Corp. (MNKD) already saw the completion of two successful Phase III trials in 2013. Now, the company has filed for approval of the drug from the FDA, and a verdict is due sometime around the middle of 2014 (if not sooner).
- [By Rich Smith]
Money-losing diabetes drug researcher MannKind (NASDAQ: MNKD ) caught a financial lifeline Monday, announcing that investment advisor Deerfield Management Company has committed to loan it $160 million.
- [By Dan Caplinger]
Lately, the stock market has turned on every word from the Federal Reserve, and so this morning's comments from Federal Reserve Chairwoman Janet Yellen received a huge amount of attention from investors Monday. With Yellen offering a much more encouraging assessment of how long interest rates might remain low in order to stimulate and sustain economic growth, stocks climbed sharply, with the Dow posting triple-digit gains. Yet for MannKind (NASDAQ: MNKD ) , Momenta Pharmaceuticals (NASDAQ: MNTA ) , and Idera Pharmaceuticals (NASDAQ: IDRA ) , the news today was far from good, as all three stocks suffered declines of 10% or more.
Top Healthcare Equipment Companies To Invest In Right Now: Stream Group Ltd (SGO)
Stream Group Limited, formerly LongReach Group Limited, is an Australia-based company operating in the information and communications technology (ICT) sector. The Company is engaged in the design, integration, installation and maintenance of integrated information and communications technology based products and services to the defense, public safety and security sectors, as well as for government, telecommunications and corporate customers, both locally and internationally. The Company together with its subsidiaries is also engaged in the provision of consulting services to certain key defense organizations. In January 2013, the Company sold its C4i business. Advisors' Opinion:- [By Jonathan Morgan]
Saint-Gobain (SGO) dropped 3.7 percent to 36.87 euros. Morgan Stanley cut its rating on the stock to underweight, similar to a sell recommendation, from equal weight, saying it doesn�� see a recovery yet in the European building industry and the contribution from emerging markets will slow.
Top Healthcare Equipment Companies To Invest In Right Now: Enertopia Corp (ENRT)
Enertopia Corp (Enertopia), incorporated on November 24, 2004, is engaged in medicinal marijuana business. The Company is diverse in its pursuit of business opportunities in several sectors, including: Medicinal Marijuana, Oil and Gas, Solar PV (Photovoltaic), Solar Thermal (Hot Water), Energy Retrofits and Recovery, and Solar powered Filtered Drinking Water.
The Company no longer has any material oil and gas resources. The Company operates in two segments: renewable energy, and mining exploration and developments, which are managed separately based on fundamental differences in their operations nature.
Advisors' Opinion:- [By Peter Graham]
What�� the Catch With Lexaria Corp? According to various disclosures, a transaction or transactions of $1k has or will occur to mention Lexaria Corp in various investment newsletters. Last Friday, Lexaria Corp announced it had closed its Private Placement financing announced on March 5 for gross proceeds of $1,272,000 ��higher than the originally announced $960,000 figure due to ��verwhelming demand.��Lexaria Corp will issue 10,600,000 common shares at US$0.12 and 10,600,000 full warrants that expire on September 21, 2016 with an exercise price of US$0.25. However, the company may also accelerate the expiry date of the warrants if the stock price trades above CAD$0.40 cents for 20 consecutive days at any time after 6 months and one day has elapsed. Otherwise and in early March, Lexaria Corp reported that its board of directors had decided to make a strategic entry into the medical marijuana business by way of an ��mportant Joint Venture��with Enertopia Corp (OTCQB: ENRT). Under the terms of the Agreement, Lexaria Corp had agreed to pay Enertopia 1 million restricted common shares in return for Enertopia's participation plus 500,000 restricted common shares ENRT�� Chairman in return for his participation on the Lexaria Advisory Board. Following the issuance of these shares, Lexaria Corp will have a total of 18,431,452 shares issued and outstanding and 21,256,452 shares fully diluted. A quick look at Lexaria Corp�� financials reveals revenues of $160k (most recent reported quarter), $241k, $251k and $253k for the past four quarters along with net losses of $102k (most recent reported quarter), $126k, $58k and $48k. At the end of last January, Lexaria Corp had $66k in cash to cover $1,415k in current liabilities and $59k in other liabilities. So aside from the income statement, investors might want to look more closely at Lexaria Corp�� financing terms.
Top Healthcare Equipment Companies To Invest In Right Now: Rambus Inc.(RMBS)
Rambus Inc. engages in the creation, design, development, and licensing of patented innovations, technologies, and architectures to digital electronics products and systems. Its patented innovations include Dual Edge Clocking, which is designed to allow data to be sent on the clock pulse; Variable Burst Length that improves data transfer efficiency by allowing varying amounts of data to be sent per a memory read or write request in dynamic random access memory (DRAM) and flash memory; and FlexPhase technology, which synchronizes data output and compensates for circuit timing errors. The company also offers Channel Equalization to improve signal integrity and system margins in high speed parallel and serial link channels; Module Threading, which improves the power efficiency of a memory module by applying parallelism to module data accesses; and MicroLens optical design technology, which provides optimum utilization of high-brightness light-emitting diodes (LED) in edge-lit lighting applications. In addition, it licenses its architectures and industry-standard solutions for use in digital electronics products and systems, including XDR Memory Architecture enabling the production of DRAM; XDR2 Memory Architecture that incorporates DRAM micro-threading for graphics intensive applications, such as gaming and digital video; Mobile XDR Memory Architecture, which enables applications, such as HD video recording and 3D gaming on battery powered mobile devices; RDRAM Memory used in play stations, Intel-based personal computers, televisions, and routers; and FlexIO Processor Bus, a high speed chip-to-chip interface. Further, the company offers industry-standard chip interface solutions, including DDRx; digital logic controllers for peripheral component interconnect express and other industry standard interfaces; and custom solutions for displays, LED backlights, and general lighting. Rambus Inc. was founded in 1990 and is headquartered in Sunnyvale, Ca lifornia.
Advisors' Opinion:- [By Wallace Witkowski]
Shares of Rambus Inc. (RMBS) �declined 8.5% to $11.25 on moderate volume after the company reported adjusted earnings of 17 cents a share on revenue of $78.3 million. Analysts expected 4 cents a share on revenue of $74.3 million. However, Rambus forecast second-quarter revenue of between $69 million and $74 million, while analysts expect $74.3 million.
No comments:
Post a Comment